Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
quote
ALXN – Alexion Pharmaceuticals, Inc. –
ALXN – Alexion Pharmaceuticals, Inc. –
Quotes
Charts
News & Analysis for ALXN
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $164.00 by Raymond...
ME Staff
-
April 26, 2019
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) reported earnings of $2.39 per share beating...
ME Staff
-
April 25, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) reported earnings of $2.39 per share beating Walls...
ME Staff
-
April 25, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) has coverage initiated with a Outperform rating and...
ME Staff
-
April 10, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) had its Outperform ➝ Outperform rating reiterated by...
ME Staff
-
March 27, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) has coverage initiated with a Neutral rating and...
ME Staff
-
February 22, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) has coverage initiated with a Neutral rating
ME Staff
-
February 22, 2019
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $175.00 by Morgan...
ME Staff
-
February 12, 2019
0
Alexion Pharmaceuticals (NASDAQ:ALXN) reported earnings of $2.14 per share beating Walls...
ME Staff
-
February 4, 2019
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) had its Buy rating reiterated by Raymond...
ME Staff
-
December 21, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
December 21, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
November 16, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Entry into a Material...
ME Staff 8-k
-
October 2, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $175.00 by Barclays
ME Staff
-
September 28, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target set to $156.00 by Credit...
ME Staff
-
September 25, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $195.00 by Citigroup
ME Staff
-
September 25, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) gets downgraded to Hold by Stifel Nicolaus...
ME Staff
-
August 7, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) had its Outperform rating reiterated by Evercore...
ME Staff
-
July 26, 2018
0
Load more